Quadrivalent human vaccine - a call to action and for additional research.
Paul
P
Krogstad
James D
JD
Cherry
D000293:Adolescent; D000328:Adult; D002648:Child; D003218:Condylomata Acuminata / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D008403:Mass Screening / Q000379:methods; D030361:Papillomavirus Infections / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000276:immunology*; D017410:Practice Guidelines as Topic; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines